Aspiriant LLC’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding FNDX
Aspiriant LLC's FNDX Position: Q3 2026 in Review
Aspiriant LLC increased its Schwab Fundamental US Large Company Index ETF (FNDX) stake by 13% in Q3 2026, buying an estimated $33.7K and bringing the position to 9,250 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #325.
Aspiriant LLC first reported a position in FNDX in Q1 2018 and has held it in 12 quarters since. The position peaked at $356K in Q1 2018. 538 funds tracked by Wall St. Rank hold FNDX as of Q3 2026.
- Aspiriant LLC held 9,250 shares of Schwab Fundamental US Large Company Index ETF worth $291K as of Q3 2026.
- Aspiriant LLC bought 1,051 Schwab Fundamental US Large Company Index ETF shares in Q3 2026, an estimated $33.7K.
- Schwab Fundamental US Large Company Index ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #325 holding.
- Aspiriant LLC first reported a position in Schwab Fundamental US Large Company Index ETF in Q1 2018 and has held it in 12 quarters since.
- Aspiriant LLC's Schwab Fundamental US Large Company Index ETF position peaked at $356K in Q1 2018.
- 538 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q3 2026.
Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.